It is a pharma private limited company based in Kottayam, Kerala, India, established in 2011.
2011 | Kottayam, Kerala, India | ActiveVanchinad Pharma Private Limited, a active private limited company, was established on 19 August 2011 in Kottayam, Kerala, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51397KL2011PTC029175. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹6.00 M and a paid-up capital of ₹3.97 M.
It upholds a compliant status. Its leadership includes Jack Mathew (Director), Manoj Kumar (Director), Sebastian Varghese (Director). Past directors included Jack Mathew, Binu John, Biju Thomas. It holds ₹1.98 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Ix/564, Second Floor Parackal Building, Shastri Road, Kottayam, Kerala, 686001.
U51397KL2011PTC029175
029175
19 August 2011
₹6.00 M
₹3.97 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Vanchinad Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jack Mathew | Director | 10 Jun 2022 | Current |
| Manoj Kumar | Director | 13 Apr 2024 | Current |
| Sebastian Varghese | Director | 04 Aug 2021 | Current |
| Tomy Pampoorickal Mathew | Director | 04 Aug 2021 | Current |
| Varughese Kureekattu Joseph | Director | 13 Apr 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 26 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 26 Sep 2022 | Past |
| Pramod Abcsdd | Director | 23 Apr 2014 | Past |
| Pramod Abcsdd | Additional Director | 10 May 2019 | Past |
| Pramod Abcsdd | Additional Director | 27 Aug 2021 | Past |
| Pramod Abcsdd | Director | 26 May 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Vanchinad Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 62.63% increase. The company also saw a substantial improvement in profitability, with a 127.66% increase in profit. The company's net worth Soared by an impressive increase of 7472.5%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Vanchinad Pharma had a public holding of 77.14%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹19,800,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 May 2023 | State Bank Of India | ₹1.98 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Vanchinad Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Vanchinad Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vanchinad Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Vanchinad Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Manoj Kumar was appointed as a Director was appointed as a Director on 13 Apr 2024 & has been associated with this company since 1 year 8 months . was recorded as a recent event.
Varughese Kureekattu Joseph was appointed as a Director was appointed as a Director on 13 Apr 2024 & has been associated with this company since 1 year 8 months . was recorded as a recent event.
The activity Vanchinad Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was completed.
Progress on A charge with State Bank Of India of Rs. 19.80 M registered on 31 May 2023 with Charge ID 100729652 was modified on 08 Feb 2024. was documented.
A charge with State Bank Of India amounted to Rs. 19.80 M with Charge ID 100729652 was registered on 31 May 2023. was recorded as a recent event.
The CIN of Vanchinad Pharma Private Limited is U51397KL2011PTC029175.
Vanchinad Pharma Private Limited is headquartered at Ix/564, Second Floor Parackal Building, Shastri Road, Kottayam, Kerala, 686001.
Vanchinad Pharma Private Limited was incorporated on 19 August 2011.
The current directors of Vanchinad Pharma Private Limited are
The primary industry of Vanchinad Pharma Private Limited is Trade.
Vanchinad Pharma Private Limited is unlisted.
The authorized capital of Vanchinad Pharma Private Limited is ₹6.00 M, and the paid-up capital is ₹3.97 M.
The compliance status of Vanchinad Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX